Exelixis Stock Forecast: The Future Of Cancer Medicine With Promising Financial Growth

June 27, 2019
Ori HoltzmanThis article was written by Ori Holtzman, a Financial Analyst at I Know First

Summary:

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here
Premium Articles

Winning Stock Forecast: ENDP Returns up to 39.05% in 1 Month as Powerful Agreements Pan Out

July 9, 2018

“Medicine is the science of uncertainty and an art of probability”

-William Osler

(Source: Pixabay)

Endo International plc is a generics and specialty branded pharmaceutical company. Incorporated on October 31, 2013, the company has three segments: U.S. Generic

Read More

Pharma Stocks Forecast Winning Stock Forecast

Quick Win by the Algorithm: Corcept Therapeutics Stock Price Rallies with Strong Performance and Insitituional Support

January 24, 2018

Stock Prediction Quick Win

Read The Full Forecast

Top Stocks Winning Stock Forecast

TEVA Stock Forecast: Teva Announces Restructuring Plan After Shrank Of $57 Billion

December 26, 2017

 The article was written by Aline Rzetelna, a Financial Analyst at I Know First. 

TEVA Stock Prediction

Summary:

  • Why Teva Shrank By $57 billion In Two-And-A-Half Years
  • Teva Announces Restructuring Plan
  • I Know First Forecast for TEVA

Microsoft Stock OutlookRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

Pharma Stocks Forecast Premium Articles

Stock Price Valeant: Step by Step, Out of the Pit

July 25, 2017

This article was written by Mingyue Liu, a Financial Analyst at I Know First.

Valeant Pharmaceuticals International: Step by Step, Out of the Pit

"Medicine really matured me as a person because, as a physician, you're obviously dealing with life and death issues, issues much more serious than what we're talking about in entertainment. You can't get more serious than life and death. And if you can handle that, you can handle anything." (Ken Jeong)

Summary:

  • Debt divestiture through debt redemption and non-core business sales
  • Organic growth bolstered by potential launch of new drugs
  • Other tailwinds that may weigh on the company's growth

IBM priceRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Premium Articles

Stock Market Outlook Quick Win by the Algorithm: FDA Approval Expedites OMER’s Growth

June 20, 2017

Quick Win by the Algorithm

Read The Full Forecast

quick win

Algorithmic Performance

Alexion Stock Analysis: New Management Will Lead ALXN in a Prosperous Direction

June 20, 2017

This article was written by Jason Schwartz, a Financial Analyst at I Know First,

Alexion Stock Analysis 

Summary

  • Alexion is best known for the development of Soliris
  • Used to treat patients with PNH and aHUS, both rare medical conditions.
  • Internal investigation results in overhaul of senior management including CEO and CFO

  • Bullish I Know First Forecast for AXLN

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Algorithmic Articles Premium Articles
Pages:12»